A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors
R. T. PENSON, S. M. CAMPOS, M. V. SEIDEN, C. KRASNER, A. F. FULLER, A. GOODMAN, M. ROCHE, A. WILLMAN, A. MUZIKANSKY, U. A. MATULONIS
International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1035-1041; DOI: 10.1136/ijgc-00009577-200511000-00005